A detailed history of Goldman Sachs Group Inc transactions in Nevro Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 349,967 shares of NVRO stock, worth $1.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
349,967
Previous 307,613 13.77%
Holding current value
$1.39 Million
Previous $2.59 Million 24.63%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.71 - $10.1 $199,487 - $427,775
42,354 Added 13.77%
349,967 $1.95 Million
Q2 2024

Aug 13, 2024

SELL
$7.96 - $13.59 $3.66 Million - $6.25 Million
-459,955 Reduced 59.92%
307,613 $2.59 Million
Q1 2024

May 15, 2024

SELL
$13.56 - $20.78 $3.8 Million - $5.83 Million
-280,458 Reduced 26.76%
767,568 $11.1 Million
Q4 2023

Feb 13, 2024

BUY
$14.18 - $22.31 $6.11 Million - $9.62 Million
431,136 Added 69.89%
1,048,026 $22.6 Million
Q3 2023

May 14, 2024

SELL
$18.22 - $25.85 $7.86 Million - $11.1 Million
-431,136 Reduced 41.14%
616,890 $11.9 Million
Q3 2023

Nov 14, 2023

BUY
$18.22 - $25.85 $8.62 Million - $12.2 Million
473,343 Added 329.75%
616,890 $11.9 Million
Q2 2023

May 14, 2024

SELL
$22.62 - $39.32 $863,767 - $1.5 Million
-38,186 Reduced 21.01%
143,547 $3.65 Million
Q2 2023

Aug 14, 2023

SELL
$22.62 - $39.32 $863,767 - $1.5 Million
-38,186 Reduced 21.01%
143,547 $3.65 Million
Q1 2023

May 14, 2024

SELL
$30.17 - $41.11 $3.94 Million - $5.37 Million
-130,540 Reduced 41.8%
181,733 $6.57 Million
Q1 2023

May 11, 2023

SELL
$30.17 - $41.11 $3.94 Million - $5.37 Million
-130,540 Reduced 41.8%
181,733 $6.57 Million
Q4 2022

May 14, 2024

BUY
$36.43 - $49.4 $8.07 Million - $10.9 Million
221,418 Added 243.7%
312,273 $12.4 Million
Q4 2022

Feb 13, 2023

BUY
$36.43 - $49.4 $8.07 Million - $10.9 Million
221,418 Added 243.7%
312,273 $12.4 Million
Q3 2022

May 14, 2024

BUY
$40.66 - $53.03 $215,741 - $281,377
5,306 Added 6.2%
90,855 $4.23 Million
Q3 2022

Nov 10, 2022

BUY
$40.66 - $53.03 $215,741 - $281,377
5,306 Added 6.2%
90,855 $4.23 Million
Q2 2022

May 14, 2024

SELL
$40.85 - $77.67 $39.3 Million - $74.8 Million
-962,477 Reduced 91.84%
85,549 $3.75 Million
Q2 2022

Aug 15, 2022

SELL
$40.85 - $77.67 $355,803 - $676,505
-8,710 Reduced 9.24%
85,549 $3.75 Million
Q1 2022

May 16, 2022

BUY
$59.95 - $92.06 $89,325 - $137,169
1,490 Added 1.61%
94,259 $6.82 Million
Q4 2021

Feb 14, 2022

BUY
$81.07 - $121.29 $4.75 Million - $7.1 Million
58,551 Added 171.11%
92,769 $7.52 Million
Q3 2021

Nov 10, 2021

BUY
$101.99 - $166.36 $3.49 Million - $5.69 Million
34,218 New
34,218 $3.98 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $140M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.